161 related articles for article (PubMed ID: 32563668)
1. A consecutive case series of defects reconstructed using NovoSorb
Solanki NS; York B; Gao Y; Baker P; Wong She RB
J Plast Reconstr Aesthet Surg; 2020 Oct; 73(10):1845-1853. PubMed ID: 32563668
[TBL] [Abstract][Full Text] [Related]
2. Experience with NovoSorb® Biodegradable Temporising Matrix in reconstruction of complex wounds.
Li H; Lim P; Stanley E; Lee G; Lin S; Neoh D; Liew J; Ng SK
ANZ J Surg; 2021 Sep; 91(9):1744-1750. PubMed ID: 34085755
[TBL] [Abstract][Full Text] [Related]
3. Wound healing and dermal regeneration in severe burn patients treated with NovoSorb® Biodegradable Temporising Matrix: A prospective clinical study.
Lo CH; Brown JN; Dantzer EJG; Maitz PKM; Vandervord JG; Wagstaff MJD; Barker TM; Cleland H
Burns; 2022 May; 48(3):529-538. PubMed ID: 34407914
[TBL] [Abstract][Full Text] [Related]
4. The use of NovoSorb biodegradable temporising matrix in wound management: a literature review and case series.
Kidd T; Kolaityte V; Bajaj K; Wallace D; Izadi D; Bechar J
J Wound Care; 2023 Aug; 32(8):470-478. PubMed ID: 37572341
[TBL] [Abstract][Full Text] [Related]
5. Novosorb® Biodegradable Temporising Matrix (BTM) and its Applications.
Lim P; Li H; Ng S
Surg Technol Int; 2023 Apr; 42():. PubMed ID: 37053370
[TBL] [Abstract][Full Text] [Related]
6. NovoSorb® Biodegradable Temporising Matrix (BTM): What we learned from the first 300 consecutive cases.
Tapking C; Thomas BF; Hundeshagen G; Haug VFM; Gazyakan E; Bliesener B; Bigdeli AK; Kneser U; Vollbach FH
J Plast Reconstr Aesthet Surg; 2024 May; 92():190-197. PubMed ID: 38547552
[TBL] [Abstract][Full Text] [Related]
7. Reconstruction of an Anterior Cervical Necrotizing Fasciitis Defect Using a Biodegradable Polyurethane Dermal Substitute.
Wagstaff MJ; Caplash Y; Greenwood JE
Eplasty; 2017; 17():e3. PubMed ID: 28197297
[No Abstract] [Full Text] [Related]
8. Strategic Use of Biodegradable Temporizing Matrix (BTM) in Wound Healing: A Case Series in Asian Patients.
Chen AC; Lin TW; Chang KC; Chang DH
J Funct Biomater; 2024 May; 15(5):. PubMed ID: 38786647
[TBL] [Abstract][Full Text] [Related]
9. The use of biodegradable temporising matrix (BTM) for facial unit reconstruction with adjuvant radiotherapy-A case study.
Buick TA; Pathak AM; Jordan DJ
JPRAS Open; 2024 Jun; 40():234-237. PubMed ID: 38681529
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable temporising matrix: use of negative pressure wound therapy shows a significantly higher success rate.
Austin CL; Draper B; Larson KW; Thompson SJ
J Wound Care; 2023 Mar; 32(3):159-166. PubMed ID: 36930194
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Complex Wounds with NovoSorb
Schlottmann F; Obed D; Bingöl AS; März V; Vogt PM; Krezdorn N
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556223
[TBL] [Abstract][Full Text] [Related]
12. Artificial dermal templates: A comparative study of NovoSorb™ Biodegradable Temporising Matrix (BTM) and Integra(®) Dermal Regeneration Template (DRT).
Cheshire PA; Herson MR; Cleland H; Akbarzadeh S
Burns; 2016 Aug; 42(5):1088-1096. PubMed ID: 27222383
[TBL] [Abstract][Full Text] [Related]
13. Use of a Synthetic Dermal Matrix for Reconstruction of 55 Patients with Nongraftable Wounds and Management of Complications.
Concannon E; Damkat-Thomas L; Rose E; Coghlan P; Solanki N; Wagstaff M
J Burn Care Res; 2023 Jul; 44(4):894-904. PubMed ID: 36721959
[TBL] [Abstract][Full Text] [Related]
14. Use of a synthetic biodegradable temporising matrix after necrotising fasciitis infection of the thigh.
ALNafisee D; Casey MC; Kelly JL
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35835486
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Necrotizing Fasciitis With NovoSorb Biodegradable Temporizing Matrix and RECELL Autologous Skin Cell Suspension: A Case Series.
Austin CL; Sodade OE; Harrison B; Causa K
J Burn Care Res; 2024 Mar; 45(2):528-532. PubMed ID: 38085950
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and resource utilisation in patients with major burns treated with NovoSorb® BTM.
Betar N; Maher D; Wheatley L; Barker T; Brown J
Burns; 2023 Nov; 49(7):1663-1669. PubMed ID: 37344307
[TBL] [Abstract][Full Text] [Related]
17. Treatment of a Full-Thickness Burn Injury With NovoSorb Biodegradable Temporizing Matrix and RECELL Autologous Skin Cell Suspension: A Case Series.
Larson KW; Austin CL; Thompson SJ
J Burn Care Res; 2020 Jan; 41(1):215-219. PubMed ID: 31765469
[TBL] [Abstract][Full Text] [Related]
18. NovoSorb® biodegradable temporising matrix (BTM) in the reconstruction of cutaneous malignancies in a major cancer centre: a case series.
Devine M; Edmondson M; Gearing P; Concannon E; Findlay M; Zinn R; Webb A
ANZ J Surg; 2024 Mar; ():. PubMed ID: 38450592
[TBL] [Abstract][Full Text] [Related]
19. Use of Biodegradable Temporising Matrix (BTM) in the reconstruction of diabetic foot wounds: A pilot study.
Kuang B; Pena G; Cowled P; Fitridge R; Greenwood J; Wagstaff M; Dawson J
Scars Burn Heal; 2022; 8():20595131221122272. PubMed ID: 36157311
[TBL] [Abstract][Full Text] [Related]
20. Use of Biodegradeable Temporizing Matrix Dermal Template for Reconstruction of Upper Extremity Soft Tissue Defects with Associated Tendon Injury.
Jou C; Chepla KJ
Plast Reconstr Surg Glob Open; 2024 Jan; 12(1):e5560. PubMed ID: 38292813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
